Global Age Related Macular Degeneration Drug Competitive Landscape Professional Research Report 2024

Global Age Related Macular Degeneration Drug Competitive Landscape Professional Research Report 2024

Research Summary

Age-related macular degeneration (AMD) drugs are medications used to treat the progressive and irreversible disease that affects the central part of the retina (macula) and can lead to vision loss. The main drugs used to treat AMD are anti-VEGF (vascular endothelial growth factor) medications. These drugs work by targeting and inhibiting the growth of abnormal blood vessels that can leak and cause damage to the macula. Some examples of anti-VEGF drugs used to treat AMD include Avastin, Lucentis, and Eylea. These drugs are usually administered via injection into the affected eye by a qualified healthcare professional. Other medications may also be prescribed to manage symptoms and prevent further vision loss.

According to DIResearch's in-depth investigation and research, the global Age Related Macular Degeneration Drug market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.

The major global manufacturers of Age Related Macular Degeneration Drug include Regeneron Pharmaceuticals, Bayer HealthCare, Novartis, Roche, Kanghong Pharma etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Age Related Macular Degeneration Drug. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Age Related Macular Degeneration Drug market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Age Related Macular Degeneration Drug market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Age Related Macular Degeneration Drug industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Age Related Macular Degeneration Drug Include:

Regeneron Pharmaceuticals

Bayer HealthCare

Novartis

Roche

Kanghong Pharma

Age Related Macular Degeneration Drug Product Segment Include:

Lucentis

Eylea

Avastin

Others

Age Related Macular Degeneration Drug Product Application Include:

Hospitals

Clinics

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Age Related Macular Degeneration Drug Industry PESTEL Analysis

Chapter 3: Global Age Related Macular Degeneration Drug Industry Porter’s Five Forces Analysis

Chapter 4: Global Age Related Macular Degeneration Drug Major Regional Market Size and Forecast Analysis

Chapter 5: Global Age Related Macular Degeneration Drug Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Age Related Macular Degeneration Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Age Related Macular Degeneration Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Age Related Macular Degeneration Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Age Related Macular Degeneration Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Age Related Macular Degeneration Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Age Related Macular Degeneration Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Age Related Macular Degeneration Drug Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources